Viewing Study NCT00701493


Ignite Creation Date: 2025-12-25 @ 1:14 AM
Ignite Modification Date: 2026-01-22 @ 7:25 AM
Study NCT ID: NCT00701493
Status: COMPLETED
Last Update Posted: 2011-06-08
First Post: 2008-06-17
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1 Bioavailability Study of Topiramate Oral Liquid Formulation Compared to the Marketed Sprinkle Capsule Formulation in Healthy Adults
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Epilepsy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Topiramate View
None Topiramate oral liquid View
None TOPAMAX Sprinkle capsule View
None topiramate capsules View